Competition

  • December 16, 2025

    Cuban-Born Wrestler Claims NCAA Denied Him College Career

    An international wrestling champion who defected from Cuba in 2022 has accused the NCAA of robbing him of a chance to compete at a U.S. college because his years attending school in his home country counted against his eligibility.

  • December 16, 2025

    NCAA Escapes Former Villanova Star's Antitrust Suit

    A Villanova University basketball player who sank a buzzer-beating shot to win the 2016 championship missed the window to bring an antitrust lawsuit accusing the NCAA of unlawfully limiting his ability to earn money, a New York federal judge has ruled.

  • December 16, 2025

    Property Management Co. Faces AI Platform Antitrust Suit

    Artificial intelligence-driven insurance compliance service provider Beagle Labs Inc. has hit AppFolio with antitrust claims in federal court, alleging the property management software company told customers Beagle created cybersecurity risks in order to drive them toward AppFolio's in-house products.

  • December 16, 2025

    PVC Pipe Buyers Defend Price-Fix Conspiracy Claims

    Polyvinyl chloride pipe purchasers say they've alleged more than enough to show a Chicago federal judge that certain manufacturers participated in a plausible and illegal price-fixing conspiracy, urging the court to let their consolidated action proceed to discovery.

  • December 16, 2025

    Split 2nd Circ. Panel Revives DirecTV Case Against Nexstar

    A split Second Circuit panel on Tuesday revived DirecTV's antitrust case that accuses Nexstar Media Group of using a pair of broadcast station owners to demand excessive retransmission fees.

  • December 16, 2025

    Va. Judge Advances Most Claims In Stelara Antitrust Case

    A Virginia federal judge has allowed health insurer CareFirst's anticompetition and patent fraud claims against Johnson & Johnson to move forward in a case alleging anticompetitive behavior in relation to the immunosuppressive drug Stelara, while letting the pharmaceutical giant escape some claims of misrepresentation.

  • December 16, 2025

    Fired Top Antitrust Official Warns Of 'Politicization'

    The former No. 2 at the U.S. Department of Justice's Antitrust Division until he was terminated this year testified Tuesday about the "politicization" of antitrust enforcement.

  • December 16, 2025

    'Take It Or Leave It' Defines Network-Affiliate Ties, FCC Told

    The major TV affiliates' groups have urged the Federal Communications Commission to tackle what they call the "seriously out of balance" relationship that has developed between major national networks and local broadcasters that carry their programs.

  • December 16, 2025

    NC Cardboard Box Salesman Freed From Trade Secrets Suit

    A corrugated packing manufacturer can't hold on to its lawsuit alleging a former star salesman defected to a close competitor with its trade secrets after a North Carolina Business Court judge ruled the complaint is too vague.

  • December 16, 2025

    Visa, Mastercard Say Merchants Too Late To Join Class Action

    Visa and Mastercard told Britain's antitrust tribunal Tuesday that a number of merchants should not be allowed to join collective proceedings accusing them of unfairly imposing interchange fees on retailers after the deadline to opt in.

  • December 16, 2025

    Omni Bridgeway Taps New Antitrust, Arbitration Leaders

    The Australia-headquartered litigation funding firm Omni Bridgeway has hired new leaders for its arbitration and antitrust initiatives in the U.S., who bring experience working at the U.S. Department of Justice, the International Court of Justice and a number of law firms to the team in Washington, D.C.

  • December 16, 2025

    Apple, Amazon Accused Of Collusion In £900M Class Action

    Apple and Amazon have been hit with a £900 million ($1.2 billion) collective action at a U.K. tribunal on behalf of more than 10 million consumers who allegedly overpaid for Apple's products because of unlawful collusion between the two technology giants.

  • December 15, 2025

    2nd Circ. Won't Revive Ex-Basketball Players' NIL Claims

    The Second Circuit on Monday refused to revive a putative class action filed by former college basketball players claiming the NCAA unjustly profited from use of their names and images years after their careers ended, saying the "continuing violation doctrine" doesn't apply and the suit was filed too late.

  • December 15, 2025

    FCC Sides With Nexstar In Ohio Retransmission Dispute

    The Federal Communications Commission has dismissed a complaint by Cincinnati Bell against TV station chain Nexstar for allegedly failing to negotiate in good faith for program carriage rights to WDTN, the Nexstar-owned NBC affiliate serving Dayton, Ohio.

  • December 15, 2025

    Telecom Says It Was Upcharged 864 Times For Fiber Install

    An Iowa-based telecom has accused a Lumen unit of trying to balloon a nearly $300,000 job to $257 million by forcing it to pay per foot for each of the 864 "hair-width glass fiber strands" in a single cable that will be pulled through 50-plus miles of tunnel under Phoenix.

  • December 15, 2025

    Microsoft Seeks To Exit ChatGPT Users' OpenAI Antitrust Suit

    Microsoft has slammed a proposed class action accusing the company of bullying OpenAI into a cloud computing deal as devoid of fact and economic sense in two motions filed in California federal court, saying the plaintiffs, ChatGPT subscribers, are trying to dodge an arbitration clause in the chatbot developer's user terms.

  • December 15, 2025

    Walmart Adds To Visa, Mastercard Swipe-Fee Deal Objections

    Walmart has become the latest retailer to object to a proposed new settlement between Visa, Mastercard and a class of potentially millions of merchants to resolve two decades of antitrust litigation, claiming the class plaintiffs and counsel have "sold out their fellow class members."

  • December 15, 2025

    States Fight Sandoz Bid To Argue Duplication In Generics Row

    Multiple attorneys general have told a Connecticut federal court that Sandoz Inc. and Fougera Pharmaceuticals Inc. can't claim the states' grievances over allegations of price fixing are duplicative of claims that were already settled, since there are some claims and forms of relief that only state plaintiffs can seek.

  • December 15, 2025

    DOJ Raises Accreditation Concerns In Vet School Case

    The U.S. Department of Justice waded into a Tennessee veterinary school's antitrust case challenging the American Veterinary Medical Association's accreditation requirements, raising concerns about the risk posed by professional groups that play gatekeeping functions.

  • December 15, 2025

    NC Panel Says State's Hospital Law Is Constitutional

    North Carolina's "certificate of need" law hasn't created a monopoly nor has it restricted an eye surgeon's right to earn a living, a state court panel ruled Friday, ending for now the surgeon's yearslong suit arguing the law is facially unconstitutional.

  • December 15, 2025

    DC Circ. Urged To Revive Rail Fuel Surcharge Collusion Suit

    Rail shippers painted a story of different judges reaching opposite conclusions on the same evidence in an attempt to convince the D.C. Circuit to revive their lawsuit accusing Union Pacific, CSX, Norfolk Southern and BNSF of colluding on freight fuel surcharges.

  • December 15, 2025

    Profs, Pashman Stein Partner Back Burford In 3rd Circ. Case

    Two prominent international arbitration professors and a Pashman Stein Walder Hayden PC partner are urging the Third Circuit to revisit its decision dismissing on jurisdictional grounds Burford Capital's bid to arbitrate a dispute relating to German antitrust litigation.

  • December 15, 2025

    Texas, Toronto Stock Exchanges End Trademark Dispute

    The Texas Stock Exchange has buried the hatchet with the Toronto Stock Exchange and ended its suit seeking a court finding that the two exchanges' logos are dissimilar. 

  • December 15, 2025

    Supreme Court Turns Down Entresto Patent Fight

    The U.S. Supreme Court on Monday rejected a petition from MSN Pharmaceuticals Inc. claiming the Federal Circuit improperly applied what is known as after-arising technology when reviving a patent covering Novartis Pharmaceuticals Corp.'s blockbuster cardiovascular drug Entresto.

  • December 12, 2025

    Google To Face Publishers' Class Claims Over AdX Exchange

    A New York federal judge Friday granted class certification in a multidistrict antitrust litigation over Google's advertising technology to publishers who sold ad space through the search giant's AdX ad space marketplace, but denied certification to publishers who used Google's AdSense platform and to a proposed class of advertisers.

Expert Analysis

  • Rebuttal

    BigLaw Settlements Should Not Spur Ethics Deregulation

    Author Photo

    A recent Law360 op-ed argued that loosening law firm funding restrictions would make BigLaw firms less inclined to settle with the Trump administration, but deregulating legal financing ethics may well prove to be not merely ineffective, but counterproductive, says Laurel Kilgour at the American Economic Liberties Project.

  • Opinion

    8th Circ. Should Reaffirm False Commercial Speech's Nature

    Author Photo

    The Eighth Circuit in Goldfinch Laboratory v. Iowa Pathology Associates should assert that false commercial speech is not categorically immune from antitrust scrutiny, says Daniel Graulich at the Federal Trade Commission.

  • How Big Pharma Has Responded To FTC Delisting Demands

    Author Photo

    Looking at some statistics concerning how pharmaceutical companies have responded to the Federal Trade Commission's recent challenges to Orange Book listings raises several possible hypotheses about the FTC's strategy and effectiveness, say Ratib Ali and Celia Lu at Competition Dynamics.

  • Unpacking Ore. Law's Limits On PE Healthcare Investment

    Author Photo

    A recent Oregon law imposes significant restrictions on nonphysicians owning or controlling medical practices, but newly enacted amendments provide some additional flexibility in certain ownership arrangements without scuttling the law's intent of addressing concerns about the rise of private equity investment in healthcare, say attorneys at Debevoise.

  • 5 Ways Lawyers Can Earn Back The Public's Trust

    Author Photo

    Amid salacious headlines about lawyers behaving badly and recent polls showing the public’s increasingly unfavorable view of attorneys, we must make meaningful changes to our culture to rebuild trust in the legal system, says Carl Taylor at Carl Taylor Law.

  • Class Actions At The Circuit Courts: August Lessons

    Author Photo

    In this month's review of class action appeals, Mitchell Engel at Shook Hardy discusses key takeaways from federal appellate decisions involving topics including antitrust, immigration, consumer fraud, birthright citizenship under the Fourteenth Amendment, and product defects.

  • Series

    Hiking Makes Me A Better Lawyer

    Author Photo

    On the trail, I have thought often about the parallels between hiking and high-stakes patent litigation, and why strategizing, preparation, perseverance and joy are important skills for success in both endeavors, says Barbara Fiacco at Foley Hoag.

  • Series

    Law School's Missed Lessons: Negotiation Skills

    Author Photo

    I took one negotiation course in law school, but most of the techniques I rely on today I learned in practice, where I've discovered that the process is less about tricks or tactics, and more about clarity, preparation and communication, says Grant Schrantz at Haug Barron.

  • DOJ Whistleblower Program May Fuel Criminal Antitrust Tack

    Author Photo

    A recently launched Justice Department program that provides rewards for reporting antitrust crimes related to the U.S. Postal Service will serve to supplement the department’s leniency program, signaling an ambition to expand criminal enforcement while deepening collaboration across agencies, say attorneys at Crowell & Moring.

  • Opinion

    Bar Exam Reform Must Expand Beyond A Single Updated Test

    Author Photo

    Recently released information about the National Conference of Bar Examiners’ new NextGen Uniform Bar Exam highlights why a single test is not ideal for measuring newly licensed lawyers’ competency, demonstrating the need for collaborative development, implementation and reform processes, says Gregory Bordelon at Suffolk University.

  • A Simple Way Courts Can Help Attys Avoid AI Hallucinations

    Author Photo

    As attorneys increasingly rely on generative artificial intelligence for legal research, courts should consider expanding online quality control programs to flag potential hallucinations — permitting counsel to correct mistakes and sparing judges the burden of imposing sanctions, say attorneys at Lankler Siffert & Wohl and Connors.

  • Antitrust Scrutiny Heightens In The Cannabis Industry

    Author Photo

    Two ongoing antitrust cases signal intensified scrutiny of pricing practices, distribution restraints and exclusionary conduct in the cannabis sector, says Robin Crauthers at McCarter & English.

  • Series

    Creating Botanical Art Makes Me A Better Lawyer

    Author Photo

    Pressing and framing plants that I grow has shown me that pursuing an endeavor that brings you joy can lead to surprising benefits for a legal career, including mental clarity, perspective and even a bit of humility, says Douglas Selph at Morris Manning.

  • FTC Focus: Surprising Ways Meador And Khan Sound Alike

    Author Photo

    Since becoming a commissioner on the Federal Trade Commission, Mark Meador's public comments, speeches and writings reveal a surprising degree of continuity with former Chair Lina Khan's approach, in an indication that differing philosophies might have comparable practical effects, say attorneys at Proskauer.

  • Compliance Is A New Competitive Edge For Mortgage Lenders

    Author Photo

    So far, 2025 has introduced state and federal regulatory turbulence that is pressuring mortgage lenders to reevaluate the balance between competitive and compliant employee and customer recruiting practices, necessitating a compliance recalibration that prioritizes five key strategies, say attorneys at Mitchell Sandler.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Competition archive.